Echo Therapeutics, Inc. - FORM 10-K/A - EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14 (A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - May 1, 2014

Attached files

file filename
10-K/A - Echo Therapeutics, Inc.ecte10kadec312013.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14 (A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - Echo Therapeutics, Inc.ex31-1.htm
EX-10.31 - LICENSE DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN THE COMPANY AND MEDICAL TECHNOLOGIES INNOVATIONS ASIA, LTD, DATED DECEMBER 9, 2013. - Echo Therapeutics, Inc.ex10-31.htm
Exhibit 31.2

CERTIFICATION

I, Christopher P. Schnittker, certify that:
 
    1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of Echo Therapeutics, Inc.; and
 
    2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.


/s/ Christopher P. Schnittker
Christopher P. Schnittker, C.P.A.
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)

May 1, 2014

Echo Therapeutics, Inc. Reports